NCPA weighs in on proposal for hydrocodone combo products
Policymakers should consider alternative strategies as they examine a proposal that would put thousands of common, hydrocodone-containing products under the same restrictions as morphine and opium and make it more difficult for consumers using those drugs legitimately to relieve chronic pain, accord